Knight, Michael L.
University of Oxford
5 papers on CoChatORCID 0000-0002-8780-1630
Most cited papers
- Verified
The antigenic anatomy of SARS-CoV-2 receptor binding domain
Dejnirattisai, W., Zhou, D., Ginn, H. M., Duyvesteyn, H. M. E., Supasa, P., Case, J. B., Zhao, Y., Walter, T. S., Mentzer, A. J., Liu, C., et al. (2021) · Cell
SARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approaches
Cited by 371
- Verified
Immunogenicity of standard and extended dosing intervals of BNT162b2 mRNA vaccine
Payne, R. P., Longet, S., Austin, J. A., Skelly, D. T., Dejnirattisai, W., Adele, S., Meardon, N., Faustini, S., Al-Taei, S., Moore, S. C., et al. (2021) · Cell
SARS-CoV-2 and COVID-19 ResearchImmune responses and vaccinations
Cited by 322
- Verified
Structural basis for the neutralization of SARS-CoV-2 by an antibody from a convalescent patient
Zhou, D., Duyvesteyn, H. M. E., Chen, C.-P., Huang, C.-G., Chen, T.-H., Shih, S.-R., Lin, Y.-C., Cheng, C.-Y., Cheng, S.-H., Huang, Y.-C., et al. (2020) · Nature Structural & Molecular Biology
SARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approaches
Cited by 274
- Verified
Vaccine-induced immunity provides more robust heterotypic immunity than natural infection to emerging SARS-CoV-2 variants of concern.
Skelly, D. T., Harding, A. C., Gilbert-Jaramillo, J., Knight, M. L., Longet, S., Brown, A., Adele, S., Adland, E., Brown, H., Team, M. L., et al. (2021) · Nature Communications
SARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approaches
Cited by 216
- Verified
Two doses of SARS-CoV-2 vaccination induce more robust immune responses to emerging SARS-CoV-2 variants of concern than does natural infection.
Skelly, D. T., Harding, A. C., Gilbert-Jaramillo, J., Knight, M. L., Longet, S., Brown, A., Adele, S., Adland, E., Brown, H., Team, M. L., et al. (2021) · Nature Communications
SARS-CoV-2 and COVID-19 Researchvaccines and immunoinformatics approaches
Cited by 216
Go further with a free account
Verify every reference, keep papers in a library, and ask questions across them.
Sign up - it is free